NCT00207740 - A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma | Biotech Hunter

Enrollment

309

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Asthma

Interventions

DRUG

CNTO148

Type=exact type, unit=mg, number=50, 75, 100, 150, 200 and 300, form=injection, route=subcutaneous. Every 4 weeks partciapnts will receive injections in 4 parallel treatment arms

DRUG

Placebo

Type=exact type, unit=mg, form=injection, route=subcutaneous. Placebo will be given from from Week 0 through Week 52.

Trial Locations (57)

Unknown

Los Angeles

San Diego

Stockton

Denver

Hartford

New Haven

Chicago

Normal

River Forest

Iowa City

Baltimore

Boston

North Dartmouth

Minneapolis

St Louis

Cortland

Elmira

Charlotte

Winston-Salem

Cincinnati

Cleveland

Lake Oswego

Medford

Portland

Philadelphia

El Paso

Richmond

Bellingham

Madison

Ghent

Russel

Sofia

Ostrava

Poruba

Ústí nad Labem

Montpellier

Pessac

Tarbes

Berlin

Großhansdorf

Leipzig

Mainz

Budapest

Nyíregyháza

Székesfehérvár

Szombathely

Törökbálint

Leiden

Bieńkówka

Katowice

Lodz

Torun

Warsaw

Linköping

Stockholm

Glasgow

Southampton